Trial · NCT07904624
Registered outcomes29
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 29
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Outpatient rehabilitation dose (time) (single ART) | A2 (week 6; +/- 1 week) | Home ART duration metrics (duration/day/month, pattern date/time stamp, repetitions etc) (participant training log and extracted device metrics from ART) vs centre based therapy duration (single and combo ART only) |
| Primary | Outpatient rehabilitation dose (time) (Combined ART) | A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week) | Home ART duration metrics (duration/day/month, pattern date/time stamp, repetitions etc) (participant training log and extracted device metrics from ART) vs centre based therapy duration (single and combo ART only) |
| Primary | Adherence to Home ART (single ART) | A2 (week 6; +/- 1 week) | Home training compliancy. Participant percentage (%) compliancy for prescription of the relevant ART given to participants by the therapist. |
| Primary | Adherence to Home ART (Combined ART) | A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week) | Home training compliancy. Participant percentage (%) compliancy for prescription of the relevant ART given to participants by the therapist. |
| Primary | Device specific metrics (Single ART) | A2 (week 6; +/- 1 week) | e.g. HMAN: number of repetitions |
| Primary | Device specific metrics (Combined ART) | A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week) | e.g. HMAN: number of repetitions |
| Primary | Dropout rates (Single ART) | A4 (week 24; +/- 1 week) or withdrawn date | Dropout rates of the groups |
| Primary | Dropout rates (Combined ART and control) | A5 (1 year; +/- 1 week) or withdrawn date | Dropout rates of the groups |
| Primary | System usability scale (SUS) (0-100) (single ART) | A2 (week 6; +/- 1 week) | To quantify the usability of the ART. Higher scores mean a better outcome. |
| Primary | System usability scale (SUS) (0-100) (Combined ART) | A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week) | To quantify the usability of the ART. Higher scores mean a better outcome. |
| Secondary | Baseline Demographics | A1 (baseline; week 0-1) | e.g. age, sex, race, ethnicity, language, Charlson Comorbidity Index (CCI), diagnosis, baseline function, past 3 months prior technology utilization, social determinants etc |
| Secondary | Fugl-Meyer Assessment (FMA) (0-66) (combined ART and control) | A1 (baseline; week 0-1), A2 (week 6; +/- 1 week), A3 (week 10; +/- 1 week), A4 (week 24; +/- 1 week), A5 (week 52; +/- 1 week) | For Upper limb (UL) Assessment of non-Spinal Cord Injury (SCI) patients (combined ART and control). Higher scores mean a better outcome. |
| Secondary | Fugl-Meyer Assessment (FMA) (0-66) (single ART) | A1 (baseline; week 0-1), A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week), A4 (week 52; +/- 1 week) | For Upper limb (UL) Assessment of non-Spinal Cord Injury patients (single ART). Higher scores mean a better outcome. |
| Secondary | Action Research Arm Test (ARAT) (0-57) (combined ART and control) | A1 (baseline; week 0-1), A2 (week 6; +/- 1 week), A3 (week 10; +/- 1 week), A4 (week 24; +/- 1 week), A5 (week 52; +/- 1 month) | For Upper limb (UL) Assessment of non-SCI patients (combined ART and control). Higher scores mean a better outcome. |
| Secondary | Action Research Arm Test (ARAT) (0-57) (single ART) | A1 (baseline; week 0-1), A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week), A4 (week 52; +/- 1 week) | For Upper limb (UL) Assessment of non-SCI patients (single ART). Higher scores mean a better outcome. |
| Secondary | Hand grip strength (HGS) (combined ART and control) | A1 (baseline; week 0-1), A2 (week 6; +/- 1 week), A3 (week 10; +/- 1 week), A4 (week 24; +/- 1 week), A5 (week 52; +/- 1 week) | For Upper limb (UL) Assessment of affected upper limb patients (combined ART and control). Average of 3 scores for both hands. |
| Secondary | Hand grip strength (HGS) (single ART) | A1 (baseline; week 0-1), A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week), A4 (week 52; +/- 1 week) | For Upper limb (UL) Assessment of affected upper limb patients (single ART). Average of 3 scores for both hands. |
| Secondary | Short Physical Performance Battery (SPPB) (0-12) (combined ART and control) | A1 (baseline; week 0-1), A2 (week 6; +/- 1 week), A3 (week 10; +/- 1 week), A4 (week 24; +/- 1 week), A5 (week 52; +/- 1 week) | For Lower Limb (UL) Assessment of affected lower limb patients (combined ART and control). Higher scores mean a better outcome. |
| Secondary | Short Physical Performance Battery (SPPB) (0-12) (single ART) | A1 (baseline; week 0-1), A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week), A4 (week 52; +/- 1 week) | For Lower Limb (UL) Assessment of affected lower limb patients (single ART). Higher scores mean a better outcome. |
| Secondary | 3 Minute Walk Test (3MWT) (combined ART and control) | A1 (baseline; week 0-1), A2 (week 6; +/- 1 week), A3 (week 10; +/- 1 week), A4 (week 24; +/- 1 week), A5 (week 52; +/- 1 week) | For Lower Limb (UL) Assessment of affected lower limb patients (combined ART and control) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07904624/registered